No Result

View All Result

No products in the cart.

Home The 2MM Team

#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)

byKathleen Lau

December 25, 2020

in The 2MM Team

Reading Time: 1 min read

Check out the original article from the Lancet Haematology here.

RELATED REPORTS

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

COVID-19 susceptibility may be increased in patients with hematological malignancies compared to solid organ tumours

RelatedReports

Nivolumab may be effective in platinum-resistant ovarian cancer

Surgery

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

August 9, 2026

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Chronic Disease

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

August 5, 2026

Adalimumab aids in control of noninfectious uveitis

Chronic Disease

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

August 3, 2026

Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Regular screening of asymptomatic SARS-CoV-2 carriers may limit COVID-19 transmission

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result